Table 2 Clinicopathologic characteristics of cervical cancer patients
Case No. | Age at the time of KT (years) | Original kidney disease | Pre-KT treatment (Duration, months) | Maintenance immunosuppression | Donor source | Graft status (event) |
|---|---|---|---|---|---|---|
1 | 41 | Hypertensive nephropathy | No dialysis | CsA + steroid | Living | Survival |
2 | 25 | Unknown (no pre-KT biopsy) | PD (12) | Tacrolimus + MMF+ steroid | Living | Survival (acute rejection) |
3 | 31 | Unknown | HD (3) | CsA + MMF + steroid | Living | Survival |
4 | 28 | Chronic glomerulonephritis | HD (51) | Tacrolimus + MMF + steroid | Living | Survival (acute rejection) |
5 | 29 | IgA nephropathy | HD (1) | CsA + steroid | Living | Fail |